CIM
WST icon

Calvert Investment Management’s West Pharmaceutical WST Stock Holding History

Calvert Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,697
Closed -$398K – 620
2016
Q4 		$398K Buy
4,697
+22
+0.5% +$1.73K 0.01% 592
2016
Q3 		$348K Buy
4,675
+513
+12% +$40.7K 0.01% 618
2016
Q2 		$316K Sell
4,162
-6
-0.1% -$437 0.01% 616
2016
Q1 		$289K Buy
4,168
+664
+19% +$40K 0.01% 606
2015
Q4 		$211K Buy
+3,504
New +$211K 0.01% 656

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Calvert Investment Management's WST Position: Q1 2017 in Review

Calvert Investment Management sold out of West Pharmaceutical (WST) in Q1 2017, closing a stake of 4,697 shares — an estimated $398K sold.

Calvert Investment Management first reported a position in WST in Q4 2015 and held it in 5 quarters. The position peaked at $398K in Q4 2016. 295 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • Calvert Investment Management reported no remaining West Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 4,697 West Pharmaceutical shares in Q1 2017, an estimated $398K.
  • Calvert Investment Management first reported a position in West Pharmaceutical in Q4 2015 and held it in 5 quarters.
  • Calvert Investment Management's West Pharmaceutical position peaked at $398K in Q4 2016.
  • 295 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.